RecruitingPhase 1 / Phase 2NCT05786924
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Sponsor: Institut de Recherches Internationales Servier
Minneapolis, MN · +20 more sites
Colorectal Cancer clinical trials in Minneapolis, MN
11 recruiting colorectal cancer studies with a site in Minneapolis, MN.
All trials in Minneapolis, MN · All Colorectal Cancer trials
RecruitingPhase 2NCT07023289
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Sponsor: AbbVie
Minneapolis, MN · Rochester, MN · +20 more sites
RecruitingPhase not listedNCT03998202
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Sponsor: Wake Forest University Health Sciences
Bemidji, MN · Brainerd, MN · Coon Rapids, MN · +144 more sites
RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
Minneapolis, MN · Rochester, MN · +29 more sites
RecruitingPhase 3NCT07228832
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sponsor: Summit Therapeutics
Minneapolis, MN · Saint Louis Park, MN · +110 more sites
RecruitingNot applicableNCT07283939
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Sponsor: Alliance for Clinical Trials in Oncology
Aitkin, MN · Baxter, MN · Bemidji, MN · +357 more sites
RecruitingPhase 3NCT05863195
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Sponsor: ECOG-ACRIN Cancer Research Group
Minneapolis, MN · Rochester, MN · +60 more sites
RecruitingPhase 1NCT07216105
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Sponsor: Fate Therapeutics
Minneapolis, MN · +4 more sites
RecruitingPhase 1 / Phase 2NCT04851119
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Sponsor: Children's Oncology Group
Minneapolis, MN · +20 more sites
RecruitingPhase 1 / Phase 2NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Sponsor: Daiichi Sankyo
Minneapolis, MN · +17 more sites
RecruitingPhase not listedNCT06073431
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Sponsor: University of Rochester
Burnsville, MN · Coon Rapids, MN · Edina, MN · +222 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.